These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

416 related items for PubMed ID: 10096545

  • 1. Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma.
    Lo YM, Chan LY, Lo KW, Leung SF, Zhang J, Chan AT, Lee JC, Hjelm NM, Johnson PJ, Huang DP.
    Cancer Res; 1999 Mar 15; 59(6):1188-91. PubMed ID: 10096545
    [Abstract] [Full Text] [Related]

  • 2. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.
    Shao JY, Li YH, Gao HY, Wu QL, Cui NJ, Zhang L, Cheng G, Hu LF, Ernberg I, Zeng YX.
    Cancer; 2004 Mar 15; 100(6):1162-70. PubMed ID: 15022282
    [Abstract] [Full Text] [Related]

  • 3. Pretherapy quantitative measurement of circulating Epstein-Barr virus DNA is predictive of posttherapy distant failure in patients with early-stage nasopharyngeal carcinoma of undifferentiated type.
    Leung SF, Chan AT, Zee B, Ma B, Chan LY, Johnson PJ, Lo YM.
    Cancer; 2003 Jul 15; 98(2):288-91. PubMed ID: 12872347
    [Abstract] [Full Text] [Related]

  • 4. Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma.
    Lin JC, Wang WY, Chen KY, Wei YH, Liang WM, Jan JS, Jiang RS.
    N Engl J Med; 2004 Jun 10; 350(24):2461-70. PubMed ID: 15190138
    [Abstract] [Full Text] [Related]

  • 5. [Quantitative analysis of plasma Epstein-Barr virus (EBV) DNA for monitoring of recurrence and metastasis in nasopharyngeal carcinoma patients after radiotherapy].
    Li YH, Shao JY, Zhao MQ, Gao HY, Li LR, Guan ZZ, Zeng YX.
    Ai Zheng; 2003 Jun 10; 22(6):645-8. PubMed ID: 12948418
    [Abstract] [Full Text] [Related]

  • 6. Long-term prognostic effects of plasma epstein-barr virus DNA by minor groove binder-probe real-time quantitative PCR on nasopharyngeal carcinoma patients receiving concurrent chemoradiotherapy.
    Lin JC, Wang WY, Liang WM, Chou HY, Jan JS, Jiang RS, Wang JY, Twu CW, Liang KL, Chao J, Shen WC.
    Int J Radiat Oncol Biol Phys; 2007 Aug 01; 68(5):1342-8. PubMed ID: 17449194
    [Abstract] [Full Text] [Related]

  • 7. [Prognostic impact of plasma Epstein-Barr virus DNA concentration on distant metastasis in nasopharyngeal carcinoma].
    Hou X, Zhang L, Zhao C, Li S, Lu LX, Han F, Shao JY, Huang PY.
    Ai Zheng; 2006 Jul 01; 25(7):785-92. PubMed ID: 16831265
    [Abstract] [Full Text] [Related]

  • 8. [Significance of cell-free Epstein-Barr virus DNA in monitoring prognosis of nasopharyngeal carcinoma].
    Cao SM, Min HQ, Gao JS, Hong MH, Xiao XB, Zhang CQ, Liu XD, Zhang AL, Guo X.
    Ai Zheng; 2003 Mar 01; 22(3):302-6. PubMed ID: 12654192
    [Abstract] [Full Text] [Related]

  • 9. [Quantitative analysis of Epstein-Barr virus DNA in plasma and peripheral blood cells in patients with nasopharyngeal carcinoma].
    Zhang Y, Gao HY, Feng HX, Deng L, Huang MY, Hu B, Cheng G, Wu QL, Cui NJ, Shao JY.
    Zhonghua Yi Xue Za Zhi; 2004 Jun 17; 84(12):982-6. PubMed ID: 15312530
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Quantitative and temporal correlation between circulating cell-free Epstein-Barr virus DNA and tumor recurrence in nasopharyngeal carcinoma.
    Lo YM, Chan LY, Chan AT, Leung SF, Lo KW, Zhang J, Lee JC, Hjelm NM, Johnson PJ, Huang DP.
    Cancer Res; 1999 Nov 01; 59(21):5452-5. PubMed ID: 10554016
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Correlation between the kinetics of plasma EBV DNA levels and clinical response during treatment in patients with nasopharyngeal carcinoma].
    Peng PJ, Zhao C, Liao H, Wang FQ, Zhang L.
    Ai Zheng; 2002 Aug 01; 21(8):817-22. PubMed ID: 12478884
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Role of Epstein-Barr virus DNA measurement in plasma in the clinical management of nasopharyngeal carcinoma in a low risk area.
    Kalpoe JS, Dekker PB, van Krieken JH, Baatenburg de Jong RJ, Kroes AC.
    J Clin Pathol; 2006 May 01; 59(5):537-41. PubMed ID: 16489178
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of plasma Epstein-Barr virus DNA load as a prognostic marker for nasopharyngeal carcinoma.
    Tan EL, Looi LM, Sam CK.
    Singapore Med J; 2006 Sep 01; 47(9):803-7. PubMed ID: 16924363
    [Abstract] [Full Text] [Related]

  • 18. [Real-time quantitative PCR assay of Epstein-Barr virus in whole blood cells of nasopharyngeal carcinoma patients].
    Wang H, Deng L, Chen SH, Wang SQ, Cao Y.
    Shi Yan Sheng Wu Xue Bao; 2003 Feb 01; 36(1):32-6. PubMed ID: 12751207
    [Abstract] [Full Text] [Related]

  • 19. Comparison of Epstein-Barr virus DNA level in plasma, peripheral blood cell and tumor tissue in nasopharyngeal carcinoma.
    Shao JY, Zhang Y, Li YH, Gao HY, Feng HX, Wu QL, Cui NJ, Cheng G, Hu B, Hu LF, Ernberg I, Zeng YX.
    Anticancer Res; 2004 Feb 01; 24(6):4059-66. PubMed ID: 15736452
    [Abstract] [Full Text] [Related]

  • 20. Quantitative analysis of plasma cell-free Epstein-Barr virus DNA in nasopharyngeal carcinoma after salvage nasopharyngectomy: a prospective study.
    Wei WI, Yuen AP, Ng RW, Ho WK, Kwong DL, Sham JS.
    Head Neck; 2004 Oct 01; 26(10):878-83. PubMed ID: 15390201
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.